Skip to main content
. 2021 Jul 2;13(13):3335. doi: 10.3390/cancers13133335

Table 1.

Demographics.

Parameter n, %
Age (n = 81)
Range 12–82
Median 64
Mean ± SD 58 ± 17.4
Sex (n = 81)
Female 34, 42%
Male 47, 58%
Localization (n = 81)
Skull 30, 37%
Sacrum 27, 33.3%
Mobile spine 24, 29.7%
Recurrence (n = 81)
Yes 52, 64.2%
No 29, 35.8%
Multiple recurrences (n = 80)
Yes 24, 30%
No 56, 70%
Tumor size (in mm **)
Range 19–144
Median 43
Mean ± SD 50.6 ± 27.5
Principal treatment at diagnosis (n = 85)
Surgical 72, 84.7%
Radiotherapy 10, 11.8%
Palliative 3, 3.5%
Adjuvant therapy (n = 40)
Radiotherapy 36, 90%
Surgical 3, 7.5%
immunotherapy 1, 2.5%
Follow-up (n = 81)
Range 2–264
Median 60
Mean ± SD 69.5 ± 59.5
Patient status (n = 81)
Alive 66, 81.5%
Dead * 15, 18.5%
Overall survival (n = 81)
Range 2–264
Median (log-rank) Not reached

* = only disease-associated deaths. n denotes the number of cases with available data. ** = size was available for only 38 cases, while tumor volume was not available.